vs

Side-by-side financial comparison of CODEXIS, INC. (CDXS) and RE/MAX Holdings, Inc. (RMAX). Click either name above to swap in a different company.

RE/MAX Holdings, Inc. is the larger business by last-quarter revenue ($71.1M vs $38.9M, roughly 1.8× CODEXIS, INC.). CODEXIS, INC. runs the higher net margin — 24.7% vs 2.0%, a 22.6% gap on every dollar of revenue. On growth, CODEXIS, INC. posted the faster year-over-year revenue change (81.3% vs -1.8%). RE/MAX Holdings, Inc. produced more free cash flow last quarter ($33.5M vs $19.6M). Over the past eight quarters, CODEXIS, INC.'s revenue compounded faster (51.0% CAGR vs -4.7%).

Codexis, Inc. is a protein engineering company that develops enzymes for pharmaceutical, food and medical applications.

RE/MAX is an international real estate franchise operating in over 100 countries and territories that, in 2015, had over 100,000 agents in 6,800 offices.

CDXS vs RMAX — Head-to-Head

Bigger by revenue
RMAX
RMAX
1.8× larger
RMAX
$71.1M
$38.9M
CDXS
Growing faster (revenue YoY)
CDXS
CDXS
+83.2% gap
CDXS
81.3%
-1.8%
RMAX
Higher net margin
CDXS
CDXS
22.6% more per $
CDXS
24.7%
2.0%
RMAX
More free cash flow
RMAX
RMAX
$13.9M more FCF
RMAX
$33.5M
$19.6M
CDXS
Faster 2-yr revenue CAGR
CDXS
CDXS
Annualised
CDXS
51.0%
-4.7%
RMAX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CDXS
CDXS
RMAX
RMAX
Revenue
$38.9M
$71.1M
Net Profit
$9.6M
$1.4M
Gross Margin
94.8%
Operating Margin
27.1%
13.1%
Net Margin
24.7%
2.0%
Revenue YoY
81.3%
-1.8%
Net Profit YoY
192.5%
-75.2%
EPS (diluted)
$0.13

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CDXS
CDXS
RMAX
RMAX
Q4 25
$38.9M
$71.1M
Q3 25
$8.6M
$73.2M
Q2 25
$15.3M
$72.8M
Q1 25
$7.5M
$74.5M
Q4 24
$21.5M
$72.5M
Q3 24
$12.8M
$78.5M
Q2 24
$8.0M
$78.5M
Q1 24
$17.1M
$78.3M
Net Profit
CDXS
CDXS
RMAX
RMAX
Q4 25
$9.6M
$1.4M
Q3 25
$-19.6M
$4.0M
Q2 25
$-13.3M
$4.7M
Q1 25
$-20.7M
$-2.0M
Q4 24
$-10.4M
$5.8M
Q3 24
$-20.6M
$966.0K
Q2 24
$-22.8M
$3.7M
Q1 24
$-11.5M
$-3.4M
Gross Margin
CDXS
CDXS
RMAX
RMAX
Q4 25
94.8%
Q3 25
71.3%
Q2 25
86.3%
Q1 25
63.8%
Q4 24
83.0%
Q3 24
66.4%
Q2 24
56.6%
Q1 24
71.6%
Operating Margin
CDXS
CDXS
RMAX
RMAX
Q4 25
27.1%
13.1%
Q3 25
-220.3%
25.0%
Q2 25
-83.9%
19.3%
Q1 25
-271.6%
7.2%
Q4 24
-34.2%
5.9%
Q3 24
-129.0%
19.4%
Q2 24
-284.9%
20.6%
Q1 24
-69.6%
5.8%
Net Margin
CDXS
CDXS
RMAX
RMAX
Q4 25
24.7%
2.0%
Q3 25
-228.1%
5.4%
Q2 25
-86.6%
6.4%
Q1 25
-274.3%
-2.6%
Q4 24
-48.4%
8.0%
Q3 24
-160.8%
1.2%
Q2 24
-285.2%
4.7%
Q1 24
-67.4%
-4.3%
EPS (diluted)
CDXS
CDXS
RMAX
RMAX
Q4 25
$0.13
Q3 25
$-0.22
Q2 25
$-0.16
Q1 25
$-0.25
Q4 24
$-0.12
Q3 24
$-0.29
Q2 24
$-0.32
Q1 24
$-0.16

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CDXS
CDXS
RMAX
RMAX
Cash + ST InvestmentsLiquidity on hand
$78.2M
$118.7M
Total DebtLower is stronger
$40.1M
$432.2M
Stockholders' EquityBook value
$50.5M
$452.4M
Total Assets
$147.8M
$582.5M
Debt / EquityLower = less leverage
0.79×
0.96×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CDXS
CDXS
RMAX
RMAX
Q4 25
$78.2M
$118.7M
Q3 25
$58.7M
$107.5M
Q2 25
$66.3M
$94.3M
Q1 25
$59.8M
$89.1M
Q4 24
$73.5M
$96.6M
Q3 24
$90.3M
$83.8M
Q2 24
$73.2M
$66.1M
Q1 24
$85.5M
$82.1M
Total Debt
CDXS
CDXS
RMAX
RMAX
Q4 25
$40.1M
$432.2M
Q3 25
$39.7M
$433.3M
Q2 25
$39.4M
$434.4M
Q1 25
$29.2M
$435.3M
Q4 24
$28.9M
$436.2M
Q3 24
$28.6M
$437.2M
Q2 24
$28.4M
$438.1M
Q1 24
$28.1M
$439.0M
Stockholders' Equity
CDXS
CDXS
RMAX
RMAX
Q4 25
$50.5M
$452.4M
Q3 25
$38.5M
$448.1M
Q2 25
$55.6M
$442.4M
Q1 25
$49.6M
$433.5M
Q4 24
$66.9M
$429.5M
Q3 24
$73.4M
$423.1M
Q2 24
$61.4M
$418.4M
Q1 24
$79.3M
$412.0M
Total Assets
CDXS
CDXS
RMAX
RMAX
Q4 25
$147.8M
$582.5M
Q3 25
$124.0M
$582.2M
Q2 25
$138.2M
$574.8M
Q1 25
$128.9M
$571.4M
Q4 24
$149.0M
$581.6M
Q3 24
$148.2M
$578.6M
Q2 24
$132.0M
$571.4M
Q1 24
$149.6M
$566.7M
Debt / Equity
CDXS
CDXS
RMAX
RMAX
Q4 25
0.79×
0.96×
Q3 25
1.03×
0.97×
Q2 25
0.71×
0.98×
Q1 25
0.59×
1.00×
Q4 24
0.43×
1.02×
Q3 24
0.39×
1.03×
Q2 24
0.46×
1.05×
Q1 24
0.35×
1.07×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CDXS
CDXS
RMAX
RMAX
Operating Cash FlowLast quarter
$20.1M
$40.9M
Free Cash FlowOCF − Capex
$19.6M
$33.5M
FCF MarginFCF / Revenue
50.3%
47.1%
Capex IntensityCapex / Revenue
1.3%
10.4%
Cash ConversionOCF / Net Profit
2.09×
28.39×
TTM Free Cash FlowTrailing 4 quarters
$-23.8M
$56.8M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CDXS
CDXS
RMAX
RMAX
Q4 25
$20.1M
$40.9M
Q3 25
$-7.7M
$17.7M
Q2 25
$-18.0M
$4.6M
Q1 25
$-13.8M
$5.7M
Q4 24
$-16.5M
$59.7M
Q3 24
$-13.0M
$17.6M
Q2 24
$-12.2M
$15.9M
Q1 24
$-7.8M
$9.4M
Free Cash Flow
CDXS
CDXS
RMAX
RMAX
Q4 25
$19.6M
$33.5M
Q3 25
$-7.9M
$16.4M
Q2 25
$-20.5M
$2.9M
Q1 25
$-15.1M
$4.0M
Q4 24
$-18.2M
$53.0M
Q3 24
$-14.0M
$16.3M
Q2 24
$-12.6M
$14.0M
Q1 24
$-8.9M
$6.8M
FCF Margin
CDXS
CDXS
RMAX
RMAX
Q4 25
50.3%
47.1%
Q3 25
-91.7%
22.4%
Q2 25
-133.6%
4.0%
Q1 25
-199.6%
5.3%
Q4 24
-85.0%
73.2%
Q3 24
-109.0%
20.8%
Q2 24
-157.5%
17.8%
Q1 24
-52.2%
8.6%
Capex Intensity
CDXS
CDXS
RMAX
RMAX
Q4 25
1.3%
10.4%
Q3 25
2.1%
1.8%
Q2 25
16.4%
2.2%
Q1 25
16.7%
2.3%
Q4 24
8.3%
9.1%
Q3 24
7.8%
1.7%
Q2 24
5.0%
2.4%
Q1 24
6.6%
3.3%
Cash Conversion
CDXS
CDXS
RMAX
RMAX
Q4 25
2.09×
28.39×
Q3 25
4.45×
Q2 25
0.97×
Q1 25
Q4 24
10.28×
Q3 24
18.22×
Q2 24
4.29×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CDXS
CDXS

Segment breakdown not available.

RMAX
RMAX

Franchising Segment$50.1M70%
Broker Fees$13.9M20%
Annual Dues$7.4M10%

Related Comparisons